BioVie Inc. (BIVI) Financial Statements (2023 and earlier)
Company Profile
| Business Address |
680 W NYE LANE CARSON CITY, NV 89703 |
| State of Incorp. | NV |
| Fiscal Year End | June 30 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 12/31/2022 MRQ | 6/30/2022 | 6/30/2021 | 6/30/2020 | 6/30/2019 | 6/30/2018 | 6/30/2017 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 45,749 | 18,642 | 4,512 | 37 | 340 | 46 | 5 | ||
| Cash and cash equivalents | 45,749 | 18,642 | 4,512 | 37 | 340 | 46 | 5 | ||
| Other current assets | 93 | 376 | 334 | ||||||
| Other undisclosed current assets | 241 | 138 | (0) | ||||||
| Total current assets: | 45,990 | 18,780 | 4,605 | 413 | 674 | 46 | 5 | ||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 100 | 118 | ✕ | ✕ | ✕ | ||||
| Property, plant and equipment | (280) | ||||||||
| Intangible assets, net (including goodwill) | 1,097 | 1,212 | 1,442 | 1,671 | 1,900 | 2,130 | 2,359 | ||
| Goodwill | 346 | 346 | 346 | 346 | 346 | 346 | 346 | ||
| Intangible assets, net (excluding goodwill) | 752 | 866 | 1,096 | 1,325 | 1,555 | 1,784 | 2,013 | ||
| Other noncurrent assets | 5 | 5 | |||||||
| Other undisclosed noncurrent assets | 280 | ||||||||
| Total noncurrent assets: | 1,202 | 1,335 | 1,442 | 1,671 | 1,900 | 2,130 | 2,359 | ||
| Other undisclosed assets | 0 | ||||||||
| TOTAL ASSETS: | 47,192 | 20,115 | 6,047 | 2,084 | 2,574 | 2,175 | 2,364 | ||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 3,245 | 2,443 | 996 | 1,259 | 443 | 1,238 | 596 | ||
| Employee-related liabilities | ✕ | 354 | 125 | ||||||
| Accounts payable | 3,245 | 2,443 | 996 | 1,259 | 443 | 884 | 471 | ||
| Due to related parties | 35 | ||||||||
| Other liabilities | 339 | 1,305 | |||||||
| Other undisclosed current liabilities | 4,213 | 421 | 22,261 | ||||||
| Total current liabilities: | 7,797 | 4,169 | 996 | 23,520 | 443 | 1,238 | 631 | ||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 13,261 | 12,226 | 63 | ||||||
| Long-term debt, excluding current maturities | 13,261 | 12,139 | 63 | ||||||
| Liabilities, other than long-term debt | 66 | 48 | 576 | 173 | |||||
| Accounts payable and accrued liabilities | 173 | ||||||||
| Due to related parties | 576 | ||||||||
| Other liabilities | 48 | ||||||||
| Operating lease, liability | 66 | 87 | ✕ | ✕ | ✕ | ||||
| Other undisclosed noncurrent liabilities | 250 | 403 | |||||||
| Total noncurrent liabilities: | 13,327 | 12,274 | 63 | 826 | 576 | ||||
| Total liabilities: | 21,124 | 16,444 | 996 | 23,583 | 443 | 2,064 | 1,207 | ||
| Equity | |||||||||
| Equity, attributable to parent, including: | 26,068 | 3,671 | 5,050 | (21,499) | 2,131 | 111 | 1,157 | ||
| Common stock | 3 | 2 | 2 | 1 | 51 | 10 | 9 | ||
| Additional paid in capital | 303,137 | 254,638 | 229,934 | 19,539 | 9,342 | 4,870 | 3,483 | ||
| Accumulated deficit | (277,073) | (250,970) | (224,885) | (41,038) | (7,262) | (4,769) | (2,335) | ||
| Other undisclosed equity, attributable to parent | 0 | ||||||||
| Other undisclosed equity | (0) | ||||||||
| Total equity: | 26,068 | 3,671 | 5,050 | (21,499) | 2,131 | 111 | 1,157 | ||
| Other undisclosed liabilities and equity | 0 | ||||||||
| TOTAL LIABILITIES AND EQUITY: | 47,192 | 20,115 | 6,047 | 2,084 | 2,574 | 2,175 | 2,364 | ||
Income Statement (P&L) ($ in thousands)
| 12/31/2022 TTM | 6/30/2022 | 6/30/2021 | 6/30/2020 | 6/30/2019 | 6/30/2018 | 6/30/2017 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 2,119 | 3,287 | 8,280 | 51 | 223 | |||
| Gain (loss) on disposition of assets for financial service operations | (2,056) | 3,287 | 8,280 | (9,212) | ✕ | ✕ | ||
| Net investment income | 51 | 223 | ||||||
| Gross profit: | 2,119 | 3,287 | 8,280 | 51 | 223 | |||
| Operating expenses | (35,370) | (27,253) | (138,054) | (2,693) | (2,497) | (2,372) | (1,554) | |
| Other undisclosed operating income (loss) | 2,056 | (3,287) | (8,280) | 9,212 | (51) | (223) | ||
| Operating loss: | (35,370) | (27,253) | (138,054) | (2,693) | (2,497) | (2,372) | (1,554) | |
| Interest and debt expense | (3,955) | (2,163) | (497) | (4,772) | (0) | (41) | 222 | |
| Loss from continuing operations: | (39,325) | (29,416) | (138,551) | (7,465) | (2,497) | (2,413) | (1,332) | |
| Loss before gain (loss) on sale of properties: | (26,777) | (29,416) | (138,551) | (7,465) | (2,497) | (2,413) | (1,332) | |
| Other undisclosed net income (loss) | (705) | 3,331 | 8,302 | (9,211) | 53 | 0 | ||
| Net loss: | (40,031) | (26,084) | (130,249) | (16,677) | (2,444) | (2,413) | (1,332) | |
| Other undisclosed net income (loss) attributable to parent | (1,201) | (21) | 1 | |||||
| Net loss available to common stockholders, diluted: | (41,232) | (26,084) | (130,249) | (16,677) | (2,444) | (2,434) | (1,331) | |
Comprehensive Income ($ in thousands)
| 12/31/2022 TTM | 6/30/2022 | 6/30/2021 | 6/30/2020 | 6/30/2019 | 6/30/2018 | 6/30/2017 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (40,031) | (26,084) | (130,249) | (16,677) | (2,444) | (2,413) | (1,332) | |
| Comprehensive loss, net of tax, attributable to parent: | (40,031) | (26,084) | (130,249) | (16,677) | (2,444) | (2,413) | (1,332) | |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.